Evidence map›Paper›PMID 29979793›Full record

ArticlePloS one2018

Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.

Madalene Earp, Jonathan P Tyrer, Stacey J Winham, Hui-Yi Lin, Ganna Chornokur, Joe Dennis, Katja K H Aben, Hoda Anton-Culver, Natalia Antonenkova, Elisa V Bandera and 139 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. ARHGEF10L Promotes Cervical Tumorigenesis via RhoA-Mediated Signaling.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  5. Review
  6. Article
  7. Review
  8. p190RhoGAPs, theCells · 2019
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

149 authors at 20 institutions in 14 countries.

Madalene EarpDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, United States of America.
Jonathan P TyrerDepartment of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.
Stacey J WinhamDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, United States of America.
Hui-Yi LinDepartment of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, United States of America.
Ganna ChornokurDivision of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States of America.
Joe DennisDepartment of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.ORCID 0000-0003-4591-1214
Katja K H AbenNetherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.
Hoda Anton-CulverGenetic Epidemiology Research Institute, UCI Center for Cancer Genetics Research and Prevention, School of Medicine, Department of Epidemiology, University of California Irvine, Irvine, CA, United States of America.
Natalia AntonenkovaByelorussian Institute for Oncology and Medical Radiology Aleksandrov N.N., Minsk, Belarus.
Elisa V BanderaCancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States of America.
Yukie T BeanDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, United States of America.
Matthias W BeckmannUniversity Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.
Line BjorgeDepartment of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
Natalia BogdanovaGynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Louise A BrintonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Angela Brooks-WilsonCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada.
Fiona BruinsmaCancer Epidemiology & Intelligence Division, The Cancer Council Victoria, Melbourne, Australia.ORCID 0000-0002-9356-2015
Clareann H BunkerDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States of America.
Ralf ButzowDepartment of Pathology, Helsinki University Central Hospital, Helsinki, Finland.
Ian G CampbellCancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia.
Karen CartyCRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Jenny Chang-ClaudeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Linda S CookDivision of Epidemiology and Biostatistics, University of New Mexico, Albuquerque, NM, United States of America.
Daniel W CramerObstetrics and Gynecology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States of America.
Julie M CunninghamDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States of America.ORCID 0000-0002-8159-3025
Cezary CybulskiInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Agnieszka Dansonka-MieszkowskaDepartment of Pathology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Evelyn DespierreDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology and Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Jennifer A DohertyProgram in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Thilo DörkGynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Andreas du BoisDepartment of Gynaecology and Gynaecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Matthias DürstDepartment of Gynecology, Friedrich Schiller University, Jena, Germany.
Douglas F EastonCentre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
Diana M EcclesWessex Clinical Genetics Service, Princess Anne Hospital, Southampton, United Kingdom.
Robert P EdwardsDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of America.
Arif B EkiciInstitute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Peter A FaschingUniversity Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.
Brooke L FridleyDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States of America.
Aleksandra Gentry-MaharajGynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
Graham G GilesCancer Epidemiology & Intelligence Division, The Cancer Council Victoria, Melbourne, Australia.ORCID 0000-0003-4946-9099
Rosalind GlasspoolCRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Marc T GoodmanSamuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, United States of America.
Jacek GronwaldInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Philipp HarterDepartment of Gynaecology and Gynaecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Alexander HeinUniversity Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.
Florian HeitzDepartment of Gynaecology and Gynaecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Michelle A T HildebrandtDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Peter HillemannsGynaecology Research Unit, Hannover Medical School, Hannover, Germany.
Claus K HogdallDepartment of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Estrid HøgdallVirus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Satoyo HosonoDivision of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
Edwin S IversenDepartment of Statistics, Duke University, Durham, NC, United States of America.
Anna JakubowskaInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.ORCID 0000-0002-5650-0501
Allan JensenVirus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Bu-Tian JiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Audrey Y JungDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Beth Y KarlanWomen's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Melissa KellarDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, United States of America.
Lambertus A KiemeneyRadboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
Boon Kiong LimDepartment of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
Susanne K KjaerVirus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Camilla KrakstadDepartment of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
Jolanta KupryjanczykDepartment of Pathology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Diether LambrechtsLaboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Sandrina LambrechtsDivision of Gynecologic Oncology; Leuven Cancer Institute, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Nhu D LeCancer Control Research, BC Cancer Agency, Vancouver, BC, Canada.
Shashi LeleDepartment of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, United States of America.
Jenny LesterWomen's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Douglas A LevineGynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, United States of America.
Zheng LiDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, United States of America.ORCID 0000-0002-6141-4990
Dong LiangCollege of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, United States of America.
Jolanta LissowskaDepartment of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland.
Karen LuDepartment of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Jan LubinskiInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Lene LundvallDepartment of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Leon F A G MassugerRadboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
Keitaro MatsuoDivision of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
Valerie McGuireDepartment of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, United States of America.
John R McLaughlinPublic Health Ontario, Toronto, ON, Canada.
Iain McNeishPublic Health Ontario, Toronto, ON, Canada.
Usha MenonGynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom.
Roger L MilneCancer Epidemiology & Intelligence Division, The Cancer Council Victoria, Melbourne, Australia.
Francesmary ModugnoDepartment of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States of America.
Kirsten B MoysichDepartment of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, United States of America.
Roberta B NessThe University of Texas School of Public Health, Houston, TX, United States of America.
Heli NevanlinnaDepartment of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Kunle OdunsiDepartment of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, United States of America.
Sara H OlsonDepartment of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States of America.
Irene OrlowDepartment of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States of America.
Sandra OrsulicWomen's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
James PaulCRUK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
Tanja PejovicDepartment of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, United States of America.
Liisa M PelttariDepartment of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
Jenny B PermuthDivision of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States of America.
Malcolm C PikeDepartment of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States of America.
Elizabeth M PooleChanning Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States of America.
Barry RosenDepartment of Gynecology-Oncology, Princess Margaret Hospital, and Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Mary Anne RossingProgram in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Joseph H RothsteinDepartment of Population Health Science and Policy, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Ingo B RunnebaumDepartment of Gynecology, Friedrich Schiller University, Jena, Germany.
Iwona K RzepeckaDepartment of Pathology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Eva SchernhammerChanning Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States of America.
Ira SchwaabInstitut für Humangenetik Wiesbaden, Wiesbaden, Germany.
Xiao-Ou ShuEpidemiology Center and Vanderbilt, Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Yurii B ShvetsovCancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, United States of America.
Nadeem SiddiquiCancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, United States of America.
Weiva SiehDepartment of Population Health Science and Policy, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
Honglin SongSchool of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, United States of America.
Melissa C SoutheyDepartment of Pathology, University of Melbourne, Melbourne, Victoria, Australia.
Beata SpiewankiewiczDepartment of Gynecologic Oncology, Institute of Oncology, Warsaw, Poland.
Lara Sucheston-CampbellDepartment of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, United States of America.
Ingvild L TangenDepartment of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
Soo-Hwang TeoDivision of Cancer Etiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Kathryn L TerryDepartment of Epidemiology, Harvard School of Public Health, Boston, MA, United States of America.
Pamela J ThompsonSamuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, United States of America.
Lotte ThomsenDepartment of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Shelley S TworogerDivision of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States of America.
Anne M van AltenaDepartment of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegan, The Netherlands.
Ignace VergoteDivision of Gynecologic Oncology; Leuven Cancer Institute, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Liv Cecilie Vestrheim ThomsenDepartment of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
Robert A VierkantDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, United States of America.
Christine S WalshWomen's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Shan Wang-GohrkeGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nicolas WentzensenDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Alice S WhittemoreDepartment of Health Research and Policy, Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, United States of America.
Kristine G WicklundProgram in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Lynne R WilkensCancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, United States of America.
Yin-Ling WooDepartment of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia.
Anna H WuDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Xifeng WuDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Yong-Bing XiangDepartment of Epidemiology, Shanghai Cancer Institute, Shanghai, China.
Hannah YangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Wei ZhengVanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN, United States of America.
Argyrios ZiogasGenetic Epidemiology Research Institute, UCI Center for Cancer Genetics Research and Prevention, School of Medicine, Department of Epidemiology, University of California Irvine, Irvine, CA, United States of America.
Alice W LeeDepartment of Health Science, California State University, Fullerton, Fullerton, CA, United States of America.
Celeste L PearceDepartment of Epidemiology, University of Michigan, Ann Arbor, MI, United States of America.
Andrew BerchuckDepartment of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, United States of America.
Joellen M SchildkrautDepartment of Public Health Sciences, The University of Virginia, Charlottesville, VA, United States of America.
Susan J RamusSchool of Women's and Children's Health, University of New South Wales, Sydney, Australia.
Alvaro N A MonteiroDivision of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States of America.
Steven A NarodWomen's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
Thomas A SellersDivision of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States of America.ORCID 0000-0002-7832-0405
Simon A GaytherCenter for Cancer Prevention and Translational Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.
Linda E KelemenDepartment of Public Health Sciences, Medical University of South Carolina and Hollings Cancer Center, Charleston, SC, United States of America.
Georgia Chenevix-TrenchDepartment of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Harvey A RischDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States of America.
Paul D P PharoahDepartment of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.ORCID 0000-0001-8494-732X
Ellen L GoodeDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, United States of America.ORCID 0000-0002-9094-8326
Catherine M PhelanDivision of Population Sciences, Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States of America.
Cedars-Sinai Medical Center · USMoffitt Cancer Center · USUniversity of Copenhagen · DKMayo Clinic in Florida · USBrigham and Women's Hospital · USInternational Hereditary Cancer Center · PLMemorial Sloan Kettering Cancer Center · USNational Cancer Institute · USRadboud University Nijmegen · NLRoswell Park Comprehensive Cancer Center · USThe Maria Sklodowska-Curie National Research Institute of Oncology · PLThe University of Melbourne · AUUniversity of Cambridge · GBBeatson West of Scotland Cancer Centre · GBHaukeland University Hospital · NOHelios Dr. Horst Schmidt Kliniken Wiesbaden · DEMedizinische Hochschule Hannover · DEOregon Health & Science University · USThe University of Texas MD Anderson Cancer Center · USUniversity Malaya Medical Centre · MY

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI TWOROGER, SHELLEY S · 2000 to 2019
$77.8M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Xin Chen · 1996 to 2026
$56.2M
Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI Zhenkun Lou · 2009 to 2026
$37.0M
Risk Factors for Breast Cancer in Younger NursesR01CA050385 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI ELIASSEN, A. HEATHER, WILLETT, WALTER C. · 1989 to 2019
$32.3M
Northern California Cooperative Family Registry for Breast CancerU01CA069417 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M. · 1995 to 2010
$22.4M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
USC CANCER EPIDEMIOLOGY &BIOSTATISTICS UNITP01CA017054 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HENDERSON, BRIAN E · 1985 to 2009
$18.2M
Cancer Research UK 10119Cancer Research UK 15973Cancer Research UK 16561Cancer Research UK C490/A10119Cancer Research UK C490/A10124Cancer Research UK C490/A6187CIHR MOP-86727Medical Research Council G0501974Medical Research Council G0601891NCATS NIH HHS UL1 TR000124NCI NIH HHS K07 CA092044NCI NIH HHS K07 CA095666NCI NIH HHS K07 CA143047NCI NIH HHS K22 CA138563NCI NIH HHS N01 CN025403NCI NIH HHS N01 PC035137NCI NIH HHS N01 PC067010NCI NIH HHS P01 CA017054NCI NIH HHS P01 CA087969NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA014089NCI NIH HHS P30 CA016056NCI NIH HHS P30 CA071789NCI NIH HHS P30 CA072720NCI NIH HHS P50 CA105009NCI NIH HHS P50 CA136393NCI NIH HHS R01 CA049449NCI NIH HHS R01 CA050385NCI NIH HHS R01 CA054419NCI NIH HHS R01 CA058598NCI NIH HHS R01 CA058860NCI NIH HHS R01 CA067262NCI NIH HHS R01 CA074850NCI NIH HHS R01 CA076016NCI NIH HHS R01 CA080742NCI NIH HHS R01 CA083918NCI NIH HHS R01 CA087538NCI NIH HHS R01 CA087696NCI NIH HHS R01 CA112523NCI NIH HHS R01 CA114343NCI NIH HHS R01 CA122443NCI NIH HHS R01 CA126841NCI NIH HHS R01 CA136924NCI NIH HHS R01 CA149429NCI NIH HHS R03 CA113148NCI NIH HHS R03 CA115195NCI NIH HHS U01 CA069417NCI NIH HHS U19 CA148112NCI NIH HHS UM1 CA182910NCI NIH HHS UM1 CA186107NIAMS NIH HHS U01 AR067166
6 · The paper itself

Abstract

Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality in American women. Normal ovarian physiology is intricately connected to small GTP binding proteins of the Ras superfamily (Ras, Rho, Rab, Arf, and Ran) which govern processes such as signal transduction, cell proliferation, cell motility, and vesicle transport. We hypothesized that common germline variation in genes encoding small GTPases is associated with EOC risk. We investigated 322 variants in 88 small GTPase genes in germline DNA of 18,736 EOC patients and 26,138 controls of European ancestry using a custom genotype array and logistic regression fitting log-additive models. Functional annotation was used to identify biofeatures and expression quantitative trait loci that intersect with risk variants. One variant, ARHGEF10L (Rho guanine nucleotide exchange factor 10 like) rs2256787, was associated with increased endometrioid EOC risk (OR = 1.33, p = 4.46 x 10-6). Other variants of interest included another in ARHGEF10L, rs10788679, which was associated with invasive serous EOC risk (OR = 1.07, p = 0.00026) and two variants in AKAP6 (A-kinase anchoring protein 6) which were associated with risk of invasive EOC (rs1955513, OR = 0.90, p = 0.00033; rs927062, OR = 0.94, p = 0.00059). Functional annotation revealed that the two ARHGEF10L variants were located in super-enhancer regions and that AKAP6 rs927062 was associated with expression of GTPase gene ARHGAP5 (Rho GTPase activating protein 5). Inherited variants in ARHGEF10L and AKAP6, with potential transcriptional regulatory function and association with EOC risk, warrant investigation in independent EOC study populations.

Indexed as

A Kinase Anchor ProteinsCarcinoma, Ovarian EpithelialFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansMonomeric GTP-Binding ProteinsPolymorphism, Single NucleotideQuantitative Trait LociRho Guanine Nucleotide Exchange FactorsRisk FactorsAKAP6 protein, humanA Kinase Anchor ProteinsARHGEF10L protein, humanMonomeric GTP-Binding ProteinsRho Guanine Nucleotide Exchange Factors

Identifiers

PMID29979793
PMCPMC6034790
OpenAlexW2880429904

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.